Lead Researcher Spotlight Professor Predrag Sikiric, MD, PhD (BPC-157 Primary Investigator) Department of Pharmacology University of Zagreb School of Medicine, Zagreb, Croatia Professor Predrag Sikiric has been the primary investigator for BPC-157 research since the 1990s, leading the team that isolated and characterized this peptide from human gastric juice
The investigators found that starting at a lower dose (2 mg rather than 4 mg) partially blunted the early gastrointestinal side effects the same titrate-slowly principle that governs approved incretin drugs
Int J Mol Sci 20(20):5220
However, the interquartile ranges were significantly smaller for DIA compared to DDA especially at extreme stoichiometry values, indicating that higher intensity phosphopeptides are better quantified by DIA as expected (Fig
Benefits of DSIP While results of using DSIP may vary from one patient to another, studies have shown health benefits including: Helps promote better sleep quality Relieves emotional and psychological responses to stress Reduces oxidative stress Normalizes myocardial contractility Alters corticotropin levels Normalizes blood pressure Alters pain perception Frequently Asked Questions Are there any side effects or risks associated with using DSIP for sleep improvement